A new institute at the University of Cambridge in the UK – the Mark Foundation Institute for Integrated Cancer Medicine – is using cutting-edge analytics to maximise the use of big data sets collected from patients, with the goal of revolutionising cancer care. The Institute is a virtual entity that will exploit advances in big data processing and machine learning to capture and integrate clinical, genomic and image data collated from hundreds of cancer patients in real time. It will be funded by a US$11.7-million award to the University of Cambridge from The Mark Foundation for Cancer Research.
“Doctors have long dreamed of an objective system that can integrate all the results generated from their cancer patients, guiding comprehensive treatment decisions both for current treatment and to predict how a particular disease will behave in the future,” said Professor Richard Gilbertson, Director of the Cancer Research UK Cambridge Centre. “This is essentially an enormous mathematical problem that requires state-of-the art computational and machine learning approaches to solve. It is this problem that our new institute, funded by a visionary award from The Mark Foundation for Cancer Research, will seek to address.”